Table 1.
Complication | No. of patients (female/male) | Mean BMI | Donor gender (f/m) | Mean donor age | Mean recipient age at the time of KTX | Mean time from KTX to treatment (months) | Kidney function (eGFR ml/min/1.73 m2) | Treatment modalities | ||
---|---|---|---|---|---|---|---|---|---|---|
before urological treatment | after urological treatment | Endourological treatment (number of patients) | Open surgery treatment (no. of patients) | |||||||
Ureteral stenosis | 38 (14/24) | 27.1 | 10/28 | 40.7 | 44 | 17.1 | 30 | 48 | 29 endoureterotomy | 9* |
Lymphocoele | 10 (3/7) | 23.1 | 6/4 | 46.3 | 53.8 | 12.2 | 54.2 | 56.7 | 9 percutaneous drainage | 1 marsupialization |
Lithiasis | 5 (1/4) | 26.7 | 2/3 | 45.3 | 52 | 75.9 | 75 | 76.7 | USRL – 4 ESWL – 1 |
0 |
Urethral stenosis | 5 (1/4) | 22.8 | 4/1 | 42.5 | 41.2 | 9.4 | 47.3 | 41 | 3 urethrotomy | 1 open urethroplasty |
KTX – kidney transplantation; USRL – ureterorenoscopic lithotripsy; ESWL- extracorporeal shock wave lithotripsy ;
see ‚Results‘